Maintenance control of oral anticoagulant therapy by a chromogenic substrate assay for factor X.
Open Access
- 1 May 1980
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 33 (5) , 445-448
- https://doi.org/10.1136/jcp.33.5.445
Abstract
An amidolytic assay employing the chromogenic substrate S 2337 (Kabi Diagnostica) was used to assay factor X in 35 healthy controls and in 100 outpatients receiving oral anticoagulant therapy. This method correlated well with a coagulation assay of factor X in the control group (r = 0.88). When compared with two routine tests for the control of anticoagulant theray (Thrombotest and prothrombin ratio) good correlation was obtained between the methods, r = 0.84 and r = -0.74 respectively. These results suggest that a chromogenic substrate assay for factor X might be a suitable method for the maintenance control of oral anticoagulant therapy.This publication has 14 references indexed in Scilit:
- Control of Anticoagulant Therapy with a Chromogenic SubstratePathophysiology of Haemostasis and Thrombosis, 1979
- Determination of vitamin K sensitive coagulation factors in plasma. Studies on three methods using synthetic chromogenic substratesThrombosis Research, 1978
- New Chromogenic Peptide Substrates for Factor XaPathophysiology of Haemostasis and Thrombosis, 1978
- A new sensitive and highly specific chromogenic peptide substrate for Factor XaThrombosis Research, 1977
- Quality Control Trials in the National Reference Thromboplastin SchemeBritish Journal of Haematology, 1973
- Studies on Coumarin Anticoagulant DrugsCirculation, 1968
- Levels of Blood-coagulation Factors During Anticoagulant Therapy with PhenindioneBMJ, 1961
- THROMBOTEST A NEW METHOD FOR CONTROLLING ANTICOAGULANT THERAPYThe Lancet, 1959
- A ‘New’ Coagulation DefectBritish Journal of Haematology, 1956
- A STUDY OF THE COAGULATION DEFECT IN HEMOPHILIA AND IN JAUNDICE.*The Lancet Healthy Longevity, 1935